Transcription of 4．脳梗塞慢性期 - jsts.gr.jp
{{id}} {{{paragraph}}}
Example: marketing
4．脳梗塞慢性期 - jsts.gr.jp
TIA. 4 . 4-3 .. 1 NVAF TIA . INR .. A 70 NVAF . TIA INR B INR.. B . 2 INR A . 3 INR .. A . 4 2 .. C1 . 5 .. B . 6 . 3 4 . 4 5 .. C1 .. 1 INR .. MRI T2 ip gradient echo . microbleeds . 2 .. 3 . Circ J 2004 68. Suppl . 1195-1196 .. 3 5 . 2009 111. APTT 4 6 .. APTT . INR . 4 . Gastroenterol Endosc 2005 47 . 2691-2695 . INR .. 4 6 . 2 6 . INR 4 5 .. European Atrial Fibrillation Trial EAFT NVAF TIA. 12 INR. 1 2 3 . 4 b a . 1 . b . NVAF . 22 62 . 4 . a . 5 . TIA a . INR NVAF . 6 . INR b Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation VA-SPINAF . INR . 1 .. 7 . b . Stroke Prevention in Atrial Fibrillation SPAF NVAF . INR . 325mg/ INR . 8 . b NVAF . INR INR . INR INR . 9 6 8 . a b . ATRIA AnTicoagulation and risk factors in Atrial Fibrillation . 62 INR . INR 5 INR 15 INR INR . 10 .. 13 a . NVAF . 112. INR INR .. inclusion criteria exclusion criteria .. 44 5,000 6 8 . REduction of Athcrothrombosis for Continued Health REACH.
例に有意差なし）、アスピリン群（用量の記載なし）で13％であった10）（Ⅱa）。したがって nvaf例にワルファリンを投与する場合、脳梗塞発症・再発予防および重症化軽減のため
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: